UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 129

Sortiert nach

The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension

Clinical gastroenterology and hepatology, 2023-07, Vol.21 (7), p.1854-1863.e10

2023

Link zum Volltext

Verfügbarkeit prüfen

Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis

Liver international, 2023-10, Vol.43 (10), p.2220-2231

2023

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive tests-based risk stratification: Baveno VII and beyond

Clinical and Molecular Hepatology, 2023, 29(1), , pp.105-109

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update

Cells (Basel, Switzerland), 2022-11, Vol.11 (22), p.3531

2022

Link zum Volltext

Verfügbarkeit prüfen

Endoscopic band ligation is safe despite low platelet count and high INR

Hepatology international, 2023-10, Vol.17 (5), p.1205-1214

2023

Link zum Volltext

Verfügbarkeit prüfen

The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation

Scientific reports, 2023-01, Vol.13 (1), p.953-953, Article 953

2023

Link zum Volltext

Verfügbarkeit prüfen

Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder

European radiology, 2023-02, Vol.33 (2), p.1422-1432

2023

Link zum Volltext

Verfügbarkeit prüfen

Erratum zu: Update zum Management der portalen Hypertonie nach Baveno VII – Was ist für die Praxis relevant?

Journal für gastroenterologische und hepatologische Erkrankungen, 2023-07, Vol.21 (2), p.68-68

2023

Link zum Volltext

Verfügbarkeit prüfen

Update zum Management der portalen Hypertonie nach Baveno VII – Was ist für die Praxis relevant?

Journal für gastroenterologische und hepatologische Erkrankungen, 2022-12, Vol.20 (4), p.91-96

2022

Link zum Volltext

Verfügbarkeit prüfen

The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes

Hepatology international, 2021-10, Vol.15 (5), p.1160-1173

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event

JHEP reports, 2022-08, Vol.4 (8), p.100513-100513, Article 100513

2022

Link zum Volltext

Verfügbarkeit prüfen

Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis

JHEP reports, 2023-05, Vol.5 (5), p.100712-100712, Article 100712

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach

Clinics in liver disease, 2021-05, Vol.25 (2), p.311-326

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality

Hepatology communications, 2021-10, Vol.5 (10), p.1660-1675

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression

Journal of personalized medicine, 2022-02, Vol.12 (2), p.239

2022

Link zum Volltext

Verfügbarkeit prüfen

An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis

JHEP reports, 2023-08, Vol.5 (8), p.100789-100789, Article 100789

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease

JHEP reports, 2023-04, Vol.5 (4), p.100682-100682, Article 100682

2023

Link zum Volltext

Verfügbarkeit prüfen

Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD

JHEP reports, 2024-01, Vol.6 (1), p.100934-100934, Article 100934

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression

JHEP reports, 2023-08, Vol.5 (8), p.100751-100751, Article 100751

2023

Link zum Volltext

Verfügbarkeit prüfen

Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality

JHEP reports, 2024-01, Vol.6 (1), p.100954-100954, Article 100954

2024

Link zum Volltext

Verfügbarkeit prüfen

Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19

Journal of personalized medicine, 2021-12, Vol.11 (12), p.1264

2021

Link zum Volltext

Verfügbarkeit prüfen

Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease

JHEP reports, 2022-11, Vol.4 (11), p.100562-100562, Article 100562

2022

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers

Clinics in liver disease, 2021-05, Vol.25 (2), p.311-326

2021

Link zum Volltext

Verfügbarkeit prüfen

Reply to: “3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta”

Journal of hepatology, 2023-07, Vol.79 (1), p.e49-e50

2023

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for hepatocellular carcinoma in a patient with hepatitis B virus and hepatitis delta virus coinfection

Journal of hepatology, 2022-07, Vol.77 (1), p.256-257

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(120)

Publikationsform

Artikel
(128)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension

Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis

Non-invasive tests-based risk stratification: Baveno VII and beyond

Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update

Endoscopic band ligation is safe despite low platelet count and high INR

The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation

Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder

Erratum zu: Update zum Management der portalen Hypertonie nach Baveno VII – Was ist für die Praxis relevant?

Update zum Management der portalen Hypertonie nach Baveno VII – Was ist für die Praxis relevant?

The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event

Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis

Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach

COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality

Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression

An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis

Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease

Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression

Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality

Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19

Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease

Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers

Reply to: “3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta”

Immunotherapy for hepatocellular carcinoma in a patient with hepatitis B virus and hepatitis delta virus coinfection

Suchergebnisse filtern